Glutamatergic Synapse Dysfunction in Drosophila Neuromuscular Junctions Can Be Rescued by Proteostasis Modulation
- PMID: 35909443
- PMCID: PMC9337869
- DOI: 10.3389/fnmol.2022.842772
Glutamatergic Synapse Dysfunction in Drosophila Neuromuscular Junctions Can Be Rescued by Proteostasis Modulation
Abstract
Glutamate is the major excitatory neurotransmitter in the nervous system, and the Drosophila glutamatergic neuromuscular junctions (NMJs) offer a tractable platform to understand excitatory synapse biology both in health and disease. Synaptopathies are neurodegenerative diseases that are associated with synaptic dysfunction and often display compromised proteostasis. One such rare, progressive neurodegenerative condition, Spinocerebellar Ataxia Type 3 (SCA3) or Machado-Joseph Disease (MJD), is characterized by cerebellar ataxia, Parkinsonism, and degeneration of motor neuron synapses. While the polyQ repeat mutant protein ataxin-3 is implicated in MJD, it is unclear how it leads to impaired synaptic function. In this study, we indicated that a Drosophila model of MJD recapitulates characteristics of neurodegenerative disorders marked by motor neuron dysfunction. Expression of 78 polyQ repeats of mutant ataxin-3 protein in Drosophila motor neurons resulted in behavioral defects, such as impaired locomotion in both larval and adult stages. Furthermore, defects in eclosion and lifespan were observed in adult flies. Detailed characterization of larval glutamatergic neuromuscular junctions (NMJs) revealed defects in morphological features along with compromised NMJ functioning. Autophagy, one of the key proteostasis pathways, is known to be impaired in the case of several synaptopathies. Our study reveals that overexpression of the autophagy-related protein Atg8a rescued behavioral defects. Thus, we present a model for glutamatergic synapse dysfunction that recapitulates synaptic and behavioral deficits and show that it is an amenable system for carrying out genetic and chemical biology screens to identify potential therapeutic targets for synaptopathies.
Keywords: Drosophila neuromuscular junctions; Spinocerebellar Ataxia Type 3; autophagy; glutamatergic synapse; synapse dysfunction; synaptopathy.
Copyright © 2022 Chakravorty, Sharma, Sheeba and Manjithaya.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





Similar articles
-
Drosophila melanogaster Neuromuscular Junction as a Model to Study Synaptopathies and Neuronal Autophagy.Methods Mol Biol. 2024;2761:97-120. doi: 10.1007/978-1-0716-3662-6_9. Methods Mol Biol. 2024. PMID: 38427233
-
Caffeic acid and resveratrol ameliorate cellular damage in cell and Drosophila models of spinocerebellar ataxia type 3 through upregulation of Nrf2 pathway.Free Radic Biol Med. 2018 Feb 1;115:309-317. doi: 10.1016/j.freeradbiomed.2017.12.011. Epub 2017 Dec 13. Free Radic Biol Med. 2018. PMID: 29247688
-
A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.Neurobiol Dis. 2015 Jan;73:174-88. doi: 10.1016/j.nbd.2014.09.020. Epub 2014 Oct 7. Neurobiol Dis. 2015. PMID: 25301414
-
Machado-Joseph Disease: A Stress Combating Deubiquitylating Enzyme Changing Sides.Adv Exp Med Biol. 2020;1233:237-260. doi: 10.1007/978-3-030-38266-7_10. Adv Exp Med Biol. 2020. PMID: 32274760 Review.
-
Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance.Prog Neurobiol. 2015 Sep;132:34-58. doi: 10.1016/j.pneurobio.2015.06.004. Epub 2015 Jun 27. Prog Neurobiol. 2015. PMID: 26123252 Review.
Cited by
-
Ebselen analogues delay disease onset and its course in fALS by on-target SOD-1 engagement.Sci Rep. 2024 May 27;14(1):12118. doi: 10.1038/s41598-024-62903-5. Sci Rep. 2024. PMID: 38802492 Free PMC article.
-
Novel EAAT2 activators improve motor and cognitive impairment in a transgenic model of Huntington's disease.Front Behav Neurosci. 2023 Jun 7;17:1176777. doi: 10.3389/fnbeh.2023.1176777. eCollection 2023. Front Behav Neurosci. 2023. PMID: 37351153 Free PMC article.
-
Differential response of neurons to autophagy modulation in Huntington's disease.Autophagy Rep. 2025 Jun 30;4(1):2519102. doi: 10.1080/27694127.2025.2519102. eCollection 2025. Autophagy Rep. 2025. PMID: 40607262 Free PMC article.
-
Drosophila melanogaster Neuromuscular Junction as a Model to Study Synaptopathies and Neuronal Autophagy.Methods Mol Biol. 2024;2761:97-120. doi: 10.1007/978-1-0716-3662-6_9. Methods Mol Biol. 2024. PMID: 38427233
References
LinkOut - more resources
Full Text Sources
Molecular Biology Databases